Adv Skin Wound Care 2017 Jan;30(1):27-34
Ya-Ting Ke, RN, is a Head Nurse, Emergency Department, Chi-Mei Medical Center, Tainan, Taiwan; and Doctoral Student, School of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan. Chia-Chi Kuo, RN, is an Advanced Practice Nurse, Emergency Department, Chi-Mei Medical Center, Tainan, Taiwan; and Doctoral Candidate, School of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan; and Assistant Professor, Department of Nursing, Chang Jung Christian University, Tainan, Taiwan. Acknowledgments: This work was sponsored by grants from the Chi Mei Medical Center, Tainan, Taiwan (CMHCR10110). The authors thank Li-Chien Yang, Kuei-Ching Wang, and Ling-Ling Liang, the head nurses of the Center of Evidence-Based Medicine, Nursing Department, Chi Mei Medical Center, and Chia-Hui Tsai, the Clinical Instructor of the Department of Nursing, Tajen University, Pingtung County, Taiwan, for their dedication to evidence collection and critical appraisal. They also thank attending physicians, Drs Yin-Hsun Feng and Wei-Yu Chen, and the chemotherapy team of the Division of Hematology and Oncology, Chi Mei Medical Center, for their assistance in study recruitment. The authors have disclosed that they have no financial interests related to this article. Submitted December 18, 2014; accepted in revised form August 4, 2015.
: The common adverse effects associated with targeted therapy for cancer, such as epidermal growth factor receptor inhibitors (EGFRIs), are dermatologic toxicities that cause the patient physical discomfort and affect treatment. Colloidal oatmeal lotion (COL) has been proven to help prevent dermatitis and xerosis. Evidence of its effect on EGFRI-induced dermatologic toxicities, however, is limited. Read More